AOC’s mission to promote psychedelic research

House Rejects AOC Amendment To Promote Research Into Psychedelics’ Medical Benefits

Since 1996, a US measure has prohibited the use of federal funds for “any activity that promotes the legalization of any drug or other substance in Schedule I”.

Last week, Rep. Alexandria Ocasio-Cortez proposed an amendment to this measure for the second time, which would allow researchers to study the benefits of Schedule I drugs, including psilocybin. Although 49 more reps voted in favour of the amendment than in 2019 (including 7 republicans), it was unfortunately rejected by the House with 140-285 vote.

AOC Tweeted, “We’ll keep bringing it up until the times catch up. We’re undeterred!”

PDF of article